Table 4.
Multivariate analyses for overall survival
Prognostic factors | β | SE | Wald | P-values | HR | 95% CI |
---|---|---|---|---|---|---|
Age | −0.569 | 0.449 | 1.609 | 0.205 | 0.566 | 0.235–1.364 |
Gender | 0.358 | 0.549 | 0.424 | 0.515 | 1.430 | 0.487–4.194 |
Primary tumor | 1.940 | 0.551 | 12.389 | 0.0001 | 6.958 | 2.362–20.493 |
Counts of LM | −0.665 | 0.539 | 1.521 | 0.217 | 0.514 | 0.179–1.480 |
With other metastases | −0.430 | 0.517 | 0.689 | 0.406 | 0.651 | 0.236–1.794 |
Interval time† | −0.303 | 0.427 | 0.502 | 0.479 | 0.739 | 0.320–1.706 |
Prior systemic treatment | 0.442 | 0.548 | 0.650 | 0.420 | 1.556 | 0.531–4.559 |
Note:
Interval time, time between the first liver metastases and CyberKnife® treatment.
Abbreviations: LM, liver metastases; HR, hazards ratio; CI, confidence interval; SE, standard error.